Skip to content

A study in HIV discordant partnerships to estimate the rate of transmission of HIV and to investigate factors associated with condom use.

A study in HIV discordant partnerships to estimate the rate of transmission of HIV and to investigate factors associated with condom use. - Partners of people on ART: a New Evaluation of the Risks PARTNER study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON34254
Enrollment
60
Registered
2010-09-23
Start date
2010-10-25
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV-1

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria - Confirmed HIV positive - On ART (regardless of viral load) - Age > 18 - Expected to remain under care at the clinic for as long as the participate in the study ;Has a partner not known to be HIV infected and the following criteria are met: - The partners have had unprotected penetrative anal or vaginal intercourse together in the past month (during which period the HIV negative partner was aware of the HIV status of the HIV positive partner) - The partners expect to have sex together again in the coming months - Both partners consent to attend clinic to complete a risk behaviour questionnaire every 3-6 months for as long as they participate in the study. - The HIV negative partner consents to testing for HIV at these visits. - Both partners consent to provide a separate blood sample if the HIV negative partner should become infected with HIV (this is for an anonymous comparison of viruses * results will not be linked to the partnership)

Exclusion criteria

Exclusion criteria: Pregnancy. (Only upon inclusion, if a woman (whether the negative or the positive partner) becomes pregnant during the study, then the partnership can continue in the study, if they wish to do so).

Design outcomes

Primary

MeasureTime frame
The primary analysis will be estimation of the rate of infection in partners per person year of unprotected sex partnership where the index patient has viral load

Secondary

MeasureTime frame
In secondary analyses we will also estimate (i) the rate of infection in partners per unprotected sex act where index patient has viral load

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)